Viewing Study NCT00039195


Ignite Creation Date: 2025-12-24 @ 1:30 PM
Ignite Modification Date: 2026-04-06 @ 7:45 PM
Study NCT ID: NCT00039195
Status: COMPLETED
Last Update Posted: 2016-08-10
First Post: 2002-06-06
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Chemotherapy and Rituximab With or Without Total-Body Irradiation and Peripheral Stem Cell Transplant in Treating Patients With Lymphoma
Sponsor: Memorial Sloan Kettering Cancer Center
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: 01-142
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None NIH View
None INDUSTRY View
None INDUSTRY View